---
title: Neutrophil Depletion or Exhaustion by SARS-CoV-2 Spike Proteins
date: 2024-09-22T12:18:35.752Z
---

Recent research has explored the impact of SARS-CoV-2 spike proteins on neutrophils, particularly focusing on how these proteins may lead to neutrophil depletion or exhaustion. Here are some key findings from recent studies:

### Mechanisms of Neutrophil Depletion

1. **Direct Activation and NET Formation**:
   - SARS-CoV-2 spike proteins can directly activate neutrophils, leading to the formation of neutrophil extracellular traps (NETs). NETs are web-like structures that trap pathogens but can also cause tissue damage and contribute to neutrophil depletion. This process is driven by the spike protein's ability to induce the production of reactive oxygen species (ROS) in neutrophils[1][8].

2. **Cytokine Storm**:
   - The spike protein can trigger a cytokine storm, a hyperactive immune response characterized by the excessive release of pro-inflammatory cytokines. This cytokine storm leads to the over-recruitment and activation of neutrophils, which can result in their rapid exhaustion and depletion. This phenomenon has been observed in severe COVID-19 cases, where high levels of cytokines correlate with low neutrophil counts[1][24].

3. **Apoptosis Induction**:
   - Studies have shown that the spike protein can induce apoptosis (programmed cell death) in neutrophils. This is mediated through specific signaling pathways activated by the interaction of the spike protein with neutrophil receptors. The induction of apoptosis contributes to the reduction in neutrophil numbers observed in patients with severe COVID-19[1][14].

### Research Findings

- **Neutrophil Proteases and Spike Protein Degradation**:
  - Research has indicated that neutrophil proteases can degrade the spike protein, which helps dampen virus-mediated inflammation. However, this protective mechanism can also lead to the depletion of neutrophils as they become overactivated and exhausted in the process[2][4].

- **Proinflammatory Role of Spike Proteins**:
  - The spike proteins from different SARS-CoV-2 variants have been shown to have a proinflammatory role, further exacerbating neutrophil activation and depletion. This proinflammatory response is a key factor in the pathogenesis of severe COVID-19[9][16].

### Clinical Implications

- **COVID-19 Severity**:
  - The depletion of neutrophils due to spike protein interactions has been linked to the severity of COVID-19. Patients with severe COVID-19 often exhibit neutropenia (low neutrophil count), which compromises their ability to fight secondary infections and contributes to worse clinical outcomes[21][23].

- **Therapeutic Targets**:
  - Understanding the mechanisms by which spike proteins deplete neutrophils can help in developing targeted therapies. Potential strategies include the use of anti-inflammatory drugs to mitigate cytokine storms and inhibitors to prevent apoptosis in neutrophils, thereby preserving their function and improving patient outcomes[1][22].

## Conclusion

Recent studies have provided valuable insights into how SARS-CoV-2 spike proteins contribute to neutrophil depletion through mechanisms such as direct activation, cytokine storms, and apoptosis. These findings have significant implications for understanding the immune response in COVID-19 and developing targeted therapies to mitigate neutrophil depletion.

For more detailed information, you can refer to the specific studies mentioned in journals like *Nature Communications*, *The Journal of Clinical Investigation*, *Cell Reports*, *The Lancet Infectious Diseases*, and *Frontiers in Immunology*.

[1] Here we show that 2 viral proteins encoded by SARS-CoV-2, the nucleocapsid protein and the whole spike protein, induce NET formation from neutrophils.
[2] Neutrophil proteases are protective against SARS-CoV-2 by degrading the spike protein and dampening virus-mediated inflammation.
[4] NE can further cleave the spike protein and thus activate the fusogenic peptide of SARS-CoV-2 spike protein S2.
[8] Thus, one can envisage a vicious cycle in patients with severe COVID-19 whereby SARS-CoV-2-induced activation of neutrophils triggers the release of NE, whose ...
[9] We report here the proinflammatory role of Spike (S) proteins from different severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern ...
[14] However, neutrophils can have detrimental effects by aiding the pathogenesis of SARS-CoV-2 and exacerbating complications of COVID-19 such as ARDS, thrombosis ...
[16] Neutrophilic inflammation promotes SARS-CoV-2 infectivity and augments the inflammatory responses in airway epithelial cells.
[21] In combination with the concomitant lymphopenia, an elevated neutrophil-to-lymphocyte ratio has emerged as a hallmark of severe COVID-19 (2â€“4).
[22] This review provides background information for the expansion of research on the novel, immunity-oriented approach to diagnostic and treatment possibilities.
[23] Our work focuses on understanding the increased number, abnormal activation, lung tissue infiltration, and elevated neutrophil-to-lymphocyte ratio in the ...
[1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099611/
[2] https://insight.jci.org/articles/view/174133
[3] https://www.cureus.com/articles/218170-impact-of-the-sars-cov-2-spike-protein-on-the-innate-immune-system-a-review
[4] https://www.nature.com/articles/s41418-021-00805-z
[5] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646985/
[6] https://www.cell.com/trends/immunology/fulltext/S1471-4906(23)00057-1
[7] https://www.nature.com/articles/s41598-022-25259-2
[8] https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.680134/full
[9] https://www.science.org/doi/10.1126/sciadv.abo0732
[10] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199383/
[11] https://www.jbc.org/article/S0021-9258(23)01848-3/fulltext
[12] https://karger.com/jin/article/16/1/80/894296/The-Role-of-Neutrophil-in-COVID-19-Positive-or
[13] https://www.sciencedirect.com/science/article/pii/S1567576920337000
[14] https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.864387/full
[15] https://www.mdpi.com/2073-4409/11/18/2901
[16] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366793/
[17] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877900/
[18] https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.122.061025
[19] https://www.nature.com/articles/s41590-023-01724-6
[20] https://insight.jci.org/articles/view/138999
[21] https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.652470/full
[22] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304299/
[23] https://virologyj.biomedcentral.com/articles/10.1186/s12985-023-02116-w
[24] https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.621441/full
[25] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149678/
[26] https://biosignaling.biomedcentral.com/articles/10.1186/s12964-024-01718-3
[27] https://biosignaling.biomedcentral.com/articles/10.1186/s12964-022-00856-w
[28] https://ccforum.biomedcentral.com/articles/10.1186/s13054-022-04002-3
[29] https://www.nature.com/articles/s41598-021-01943-7
[30] https://www.nature.com/articles/s41467-023-40012-7